We’re here for you

Helping you take control of your health and wellbeing.

Health A-Z

Your complete guide to conditions, symptoms and treatments, including what to do and when to get help.


Get the latest NHS information and advice about coronavirus (COVID-19).

Mental health and wellbeing

If you’re feeling stressed, anxious or depressed, or just want to feel happier, we’re here to help.

Diazepam will no longer be prescribed for flight phobia.

People often come to us requesting the doctor or nurse to prescribe diazepam for fear of flying or assist with sleep during flights. Diazepam is a sedative, which means it makes you sleepy and more relaxed. There are a number of very good reasons why prescribing this drug is not recommended.

According to the prescribing guidelines doctors follow (British National Formulary) diazepam is contraindicated (not allowed) for treating phobias (fears). It also states that “the use of benzodiazepines to treat short-term ‘mild’ anxiety is inappropriate.” Your doctor would be taking a significant legal risk by prescribing against these guidelines. They are only licensed short term for a crisis in generalised anxiety. If this is the case, you should be getting proper care and support for your mental health and not going on a flight. Fear of flying in isolation is not a generalised anxiety disorder.

Although plane emergencies are a rare occurrence there are concerns about reduced awareness and reaction times for patients taking Diazepam which could pose significant risk to themselves and others due to not being able to react in a manner which could save their life in the event of an emergency on board necessitating evacuation.

Medicines A-Z

Find out how your medicine works, how and when to take it, possible side effects and answers to your common questions.

Pregnancy and Baby Guide

Whatever you want to know about getting pregnant, being pregnant or caring for your new baby, you should find it here.

Update on Wegovy (semaglutide) – June 2023

NHS West Yorkshire Integrated Care Board (ICB) welcomes the news that considerations are being given on how to expand weight management offers to people in England. Wegovy is not currently available for prescribing. This is likely to be rolled out as an initial pilot project and at this time we do not know which areas will be pilot sites. We greatly appreciate that demand for these medications is likely to be high and will work in the coming weeks to gain clarity of what is likely to be the offer.
As supplies of Wegovy have not yet been made available in the UK by the manufacturer, there has been an increase in demand for off label use of Ozempic and Rybelsus, which has led to shortages of these drugs to treat people with type 2 diabetes. Ozempic and Rybelsus are only licensed for Type 2 Diabetes and as such must only be used for patients with type 2 diabetes.
West Yorkshire ICB does not support the off-label use of Ozempic or Rybelsus for weight loss treatment.
We know that obesity is particularly prevalent in low Index of Multiple Deprivation (IMD) areas and those most in need may not be able to afford to self-fund such a medication, so we want to ensure our commissioning policy reflects this. We will work to keep you updated on timescales and more detailed plans as they develop.
Other information in case helpful
Link to: NICE TA875; Semaglutide for managing obesity: A briefing for Integrated Care Systems.
NHS medical director Professor Sir Stephen Powis said:
‘Tackling obesity is a key part of the NHS Long Term Plan – it can have devastating consequences for the nation’s health, leading to serious health conditions and some common cancers as well as resulting in significant pressure on NHS services. Pharmaceutical treatments offer a new way of helping people with obesity gain a healthier weight and this new pilot will help determine if these medicines can be used safely and effectively in non-hospital settings as well as a range of other interventions we have in place’.